Newsletter Signup | Join Community
Treatment of stage IV esophageal cancer;
Surgery, radiation chemotherapy, and precision cancer medicines may be part of stage II - III esophageal cancer treament
Testing for EGFR in esophageal cancer can identify patients that may benefit from Iressa and other targeted therapies
Peter Enzinger, MD, director of the Center for Esophageal Cancer at Dana-Farber reports effectiveness of CAPOX+B+T.
Selected Subsets of Patients with Esophageal Cancer Respond to Iressa®
Variables Including Hospital Volume Influence Survival in Esophageal Cancer
Surgery + chemoradiation doubles survival compared to surgery alone for treatment of stage III-IV esophageal cancer
Combo of Radiation Therapy and Chemotherapy, without Surgery, Effective against Some Stage I to IV Esophageal Cancers
Minimally Invasive Screening Options for Barrett’s Esophagus
Regular use of NSAIDS can reduce the risk of esophageal and other cancers.
Chemotherapy/Radiation Prior to Surgery Improves Survival over Surgery Alone in Esophageal Cancer
Pre-Operative Chemotherapy Appears to Improve Survival in Esophageal Cancer
Esophageal Cancer on the Rise .
Localized Cancer of the Esophagus: Adding Chemotherapy to Radiation Therapy May Improve Survival Rates.Treatment for can
Surgery May Alleviate Symptoms and Improve Quality of Life in Persons with Advanced Cancer of the Esophagus
Radiofrequency Ablation in Barrett’s Esophagus May Prevent Esophageal Cancer
Older Persons with Cancer of the Esophagus May Benefit from Surgery.
Survival Among Patients with Esophageal Cancer Is Improved with Combined Therapy Followed by Surgery
Neoadjuvant Treatment with Combination Radiation Chemotherapy for Patients with Localized Cancer of the Esophagus
Epirubicin Plus Cisplatin Plus Prolonged Fluorouracil Is Active against Advanced Adenocarcinoma of the Esophagus
Genetic testing beginning to make a difference in esophageal cancer
Age Should not Limit Consideration of Aggressive Surgical Procedures in Elderly Persons with Cancer of the Esophagus
PET Scanning Valuable for Staging of Esophageal Cancer
PET Scans Improve Staging Accuracy in Esophageal Cancer
Neoadjuvant Chemotherapy plus Radiation Improves Survival in Esophageal Cancer
Improved Survival After Surgery for Esophageal Cancer
Treatment for Localized Esophageal Cancer: Surgery Alone Is as Effective as Surgery with Chemotherapy and Radiation
Barrett’s Esophagus Increases Risk of Esophageal Cancer and Mortality
Xeloda® and Eloxatin® Evaluated in Esophageal and Gastric Cancers
New Study Confirms Increased Incidence of Adenocarcinoma of the Esophagus in White Americans
Scalding Hot Tea May Increase the Risk of Esophageal Cancer
Alcohol-induced Flushing Linked with Esophageal Cancer.
Preoperative Chemoradiotherapy Improves Survival in Esophageal Cancer
National Esophageal Cancer Awareness Month on CancerConnect
Surgeon Volume Influences Outcomes in Esophageal Cancer
In addition to going to a high volume treatment center here are 10Tips for facing esophogeal cancer.
Understand treatment of stage 0 - I esophageal cancer.
Information on the treatment and management of Barrett's Esophagus
Regular Screening of Barrett’s Patients Improves Early Cancer Detection
Choosing where to have surgery for esophageal cancer may be the most important decision you make.
AMG 337 MET Inhibitor active in MET-amplified gastroesophageal junction, gastric, and esophageal cancers
Mindy Mordecai & John Lipham, MD, University of Southern California discuss ECAN's role in raising GERD awareness
Surgeon experience is critical consideration for esophageal cancer surgery
Esophageal cancer patients should not be denied treatment solely based on advanced age
Lancet article suggest brachytherapy may be superior to stents for esophageal cancer dysphagia
According to Swedish investigators high intake of anti-oxidants may reduce cancer risk
Treatment of stage I-II esophageal cancer with chemo and surgery produces similar outcomes to surgery alone
Combined Chemotherapy, Radiation Therapy and Surgery is Superior to Surgery Alone for the Treatment of Esophageal Cancer
Iressa Improves Progression-Free Survival in Metastatic Esophageal Cancer
PET Scans improve detection of esophageal cancer and better determine operability
Minimally Invasive Endoscopic Procedure Effective in Early Esophageal Cancer
Two Approaches to Reversing Barrett’s Esophagus May Be Successful
Chemoradiotherapy plus Surgery Improves Esophageal Cancer Survival
Neoadjuvant Treatment for Esophageal Cancer Remains Promising
Risk Factors Play Large Role in the Development of Esophageal Cancer.
Low Levels of Selenium Associated With Esophageal and Gastric Cancers in China
Chemotherapy before Surgery May Improve Survival over Surgery Alone for Certain Persons with Cancer of the Esophagus
Survival of patients with esophageal cancer is dependent on the extent of spread (stage) at the time of diagnosis.
Barrett’s Esophagus: Surgery May Reduce the Risk of Progression to Cancer
Long-Term Survival Improved with Neoadjuvant Therapy in Esophageal Cancer
Prolonged Survival in Patients with Recurrent Squamous Cell Cancer of the Esophagus.
Endosonography Improves the Staging of Cancer of the Esophagus
Mitomycin, Cisplatin and Fluorouracil: A New Standard Treatment for Patients with Advanced Cancer of the Esophagus
Taxane Chemotherapy for Treatment of Patients with Recurrent Esophageal Cancer
Esophagectomy in Elderly Patients Results in Similar Outcomes as for Younger Patients
ECF Chemotherapy Prior to and Following Surgery Improves Survival in Early Gastric and Esophageal Cancer
ERCC1 Levels Strongly Associated with Survival in Esophageal Cancer
Additional Chemotherapy Improves Survival in Esophageal Cancer
Esophagitis Increases Risk of Esophageal Cancer
Advexin® Promising for Inoperable, Refractory Esophageal Cancer
Use of Metal Devices, Called Stents, May Help Improve Swallowing Ability in Persons with Esophageal Cancer
Cancer of the Esophagus: Combined Radiation Therapy, Chemotherapy, and Surgery May Prolong Survival.
Photodynamic Laser Therapy is Equivalent or Superior to Thermal Ablation Therapy for Palliation of Esophageal Cancer
Combined chemotherapy and radiation Improves survival of patients with localized cancer of the esophagus
Chemotherapy and Radiation Therapy May Replace Surgery in Early Esophageal Cancer
Comprehensive Study of Esophageal Cancer Reveals Several Molecular Subtypes, Provides New Insight into Prevalent Disease
Barrett’s Esophagus May Carry Lower Risk of Esophageal Cancer Than Previously Reported
Aspirin and NSAIDS may Confer Protective Effect Against Esophageal Cancer
Advances in the management of stomach (gastric), and esophageal cancer have been slow.
Erbitux® Combinations Evaluated in Rectal and Esophageal Cancer
Cancer of the Esophagus: Combined Radiation Therapy, Chemotherapy, and Surgery May Prolong Survival
Older Persons with Cancer of the Esophagus May Benefit from Surgery
Reassuring Findings Regarding Oral Bisphosphonates and Esophageal Cancer
New Analysis Suggests Possible Increase in Esophageal Cancer Risk Among Users of Oral Bisphosphonates
Neoadjuvant Chemotherapy and Radiation Improve Survival Compared to Surgery Alone in Operable Esophageal Cancer.
Survival Period for Esophageal Cancer Is Tied to Race and Income
Gemzar®/Cisplatin Appears Promising in Advanced Esophageal Cancer
Dietary Fiber May Reduce Risk of Oral, Pharyngeal and Esophageal Cancer.
Chemotherapy and Radiation Therapy Followed by Surgery Does Not Improve Survival in Patients
John Hopkins Researchers develop new test to screen for esophageal cancer.…